Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique
Recruiting
N/A
Interventional Study
Nd:YAG Laser
Sclerotherapy
Diode Laser
Reticular Veins
Telangiectasias
CLaCS Technique
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Ain Shams University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18-60 years.
* Both sexes.
* Presence of reticular veins and/or telangiectasias (CEAP classification C1).
* Fitzpatrick skin types II-V.
* Patients seeking cosmetic treatment.
Exclusion Criteria:
* Pregnancy or lactation.
* History of deep vein thrombosis.
* Co…
Contacts